1.Kandel D: Stages in adolescent involvement in drug use. Science 1995; 190:912—914
Â
2.Kandel D, Faust R: Sequence and stages in patterns of adolescent drug use. Arch Gen Psychiatry 1975; 32:923—932
Â
3.Kandel D, Yamaguchi K: Stages of drug involvement in the US population, in Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Edited by Kandel D. New York, Cambridge University Press, 2002, pp 65—89
Â
4.Young S, Mikulich S, Goodwin M, Hardy J, Martin C, Zoccalillo M, Crowley T: Treated delinquent boys’ substance use: onset, pattern, relationship to conduct and mood disorders. Drug Alcohol Depend 1995; 37:149—162
Â
5.Golub A, Johnson B: The shifting importance of alcohol and marijuana as gateway substances among serious drug abusers. J Stud Alcohol 1994; 55:607—614
Â
6.Golub A, Johnson B: Substance use progression and hard drug use in inner city New York, in Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Edited by Kandel D. New York, Cambridge University Press, 2002, pp 90—112
Â
7.Mackesy-Amiti ME, Fendrich M, Goldstein PJ: Sequence of drug use among serious drug users: typical vs atypical progression. Drug Alcohol Depend 1997; 45:185—196
Â
8.Blaze-Temple D, Lo S: Stages of drug use: a community survey of Perth teenagers. Br J Addict 1992; 87:215—225
Â
9.Agrawal A, Neale M, Prescott C, Kendler K: Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet 2004; 34:217—228
Â
10.Kendler KS, Jacobson KC, Prescott CA, Neale MC: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160:687—695
Â
11.Tsuang M, Lyons M, Meyer J, Doyle T, Eisen S, Goldberg J, True W, Lin N, Tooney R, Eaves L: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55:967—972
Â
12.Vanyukov MM, Tarter RE: Genetic studies of substance abuse. Drug Alcohol Depend 2000; 15:101—123
Â
13.Brigham J, Herning R, Moss H: Event-related potentials and alpha synchronization in preadolescent boys at risk for psychoactive substance use. Biol Psychiatry 1995; 37:834—846
Â
14.Polich J, Pollock V, Bloom F: Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol Bull 1994; 115:55—73
Â
15.Koob G, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278:52—58
Â
16.Koob G, Nestler E: The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997; 9:482—497
Â
17.Jessor R, Jessor S: Problem Behavior and Psychosocial Development: A Longitudinal Study of Youth. New York, Academic Press, 1977
Â
18.Tarter R, Vanyukov M, Giancola P, Dawes M, Blackson T, Mezzich A, Clark D: Etiology of early age onset substance use disorder: a maturational perspective. Dev Psychopathol 1999; 11:657—683
Â
19.Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB: Liability to substance use disorders, 1: common mechanisms and manifestations. Neurosci Biobehav Rev 2003; 27:507—515
Â
20.Tarter RE, Vanyukov MM: Theoretical and operational framework for research into the etiology of substance use disorders. J Child Adolesc Substance Abuse 2001; 10:1—12
Â
21.Yamaguchi K: Stage of drug use progression: a comparison of methods, concepts and operationalizations, in Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Edited by Kandel D. New York, Cambridge University Press, 2002, pp 270—286
Â
22.Zimmer L, Morgan J: Marijuana Myths, Marijuana Facts: A Review of the Scientific Evidence. New York, Lindesmith Center, 1987
Â
23.Kandel D, Jessor R: The gateway hypothesis revisited, in Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. Edited by Kandel D. New York, Cambridge University Press, 2002, pp 365—372
Â
24.Tarter R: Evaluation and treatment of adolescent substance abuse: a decision tree method. Am J Drug Alcohol Abuse 1990; 16:1—46
Â
25.Spitzer RL, Williams JBW, Gibbon M, First MB: User’s Guide for the Structured Clinical Interview for DSM-III-R (SCID). Washington, DC, American Psychiatric Press, 1990
Â
26.Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM: Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39:879—883
Â
27.Vanyukov MM, Kirisci L, Tarter RE, Simkevitz HF, Kirillova GP, Maher BS, Clark DB: Liability to substance use disorders, 2: a measurement approach. Neurosci Biobehav Rev 2003; 27:517—526
Â
28.Kandel D, Yamaguchi K: Developmental stages of involvement in substance use, in Sourcebook on Substance Abuse: Etiology, Epidemiology, Assessment, and Treatment. Edited by Ott P, Tarter R, Ammerman R. Boston, Allyn & Bacon, 1999, pp 50—74
Â
29.Olds D: Prenatal and infancy home visiting by nurses: from randomized trial to community replication. Prev Sci 2002; 3:153—172
Â
30.Maziade M, Caron C, Cote R, Boutin P, Thiverge J: Extreme temperament and diagnosis: a study in a consecutive child psychiatric sample. Arch Gen Psychiatry 1990; 47:477—484
Â
31.Blackson T, Tarter R: Individual, family, and peer affiliation factors predisposing to early-age onset of alcohol and drug use. Alcohol Clin Exp Res 1994; 18:813—821
Â
32.Wilens TE, Biederman J, Spencer TJ: Attention deficit hyperactivity disorder and the psychoactive substance use disorders. Child Adolesc Psychiatr Clin N Am 1996; 5:73—91
Â
33.Whitehead A: Process and Reality. New York, Harper, 1929
Â